Bottom line
FNY vs PMAQX: the short answer
FNY (First Trust Mid Cap Growth AlphaDEX Fund) and PMAQX (MidCap Fund (f/k/a MidCap Blend Fund)) are both etfs.
But FNY is far broader, holding 227 positions to 73 for PMAQX, so beyond the top names it adds exposure PMAQX doesn't have.
PMAQX is cheaper at 0.57% vs 0.73% — a difference of $16 a year per $10,000 invested.
Over five years, FNY returned +11.1% a year vs +8.2% for PMAQX (reporting dates differ).
Updated Nov 19, 2026
FNY vs PMAQX side by side
| FNY | PMAQX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | Principal |
| Category | Mid-Cap | Mid-Cap |
| Expense ratio | 0.73% | 0.57% |
| Annual cost per $10k | $73 | $57 |
| 10-yr cost on $10k (prospectus) | — | $714 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | — |
| 1-yr return | +18.3% | +1.7% |
| 5-yr return (annualized) | +11.1% | +8.2% |
| 10-yr return (annualized) | +10.9% | +12.4% |
| Best quarter | +29.2% | +24.7% |
| Worst quarter | −22.7% | −23.9% |
| Net assets (fund) | $577.6M | $23.1B |
| Number of holdings | 227 | 73 |
| Portfolio turnover | 13% | 14% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FNY and PMAQX share none of their top holdings.
FNY top 10
- Citigroup Global Markets Inc. — 1.15%
- Etsy Inc — 0.86%
- Guardant Health Inc — 0.86%
- Pacs Group Inc — 0.86%
- Victoria's Secret & Company — 0.84%
- Amneal Pharmaceuticals Inc — 0.84%
- Enova International Inc — 0.84%
- Corcept Therapeutics Inc — 0.84%
- Ies Holdings Inc — 0.81%
- Tutor Perini Corp — 0.80%
PMAQX top 10
- HEICO Corp - Class A — 5.28%
- Brookfield Corp — 5.16%
- TransDigm Group Inc — 5.13%
- Live Nation Entertainment Inc — 4.92%
- KKR & Co Inc — 4.74%
- CBRE Group Inc — 4.56%
- Vulcan Materials Co — 4.37%
- Hilton Worldwide Holdings Inc — 3.86%
- Martin Marietta Materials Inc — 3.57%
- O'Reilly Automotive Inc — 3.36%
FAQ
What is the difference between FNY and PMAQX?
Which is cheaper, FNY or PMAQX?
Should I own both FNY and PMAQX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.